| Literature DB >> 29515664 |
Nathalie Tabin1, Sharon Mitchell1, Elaine O'Connell2, Daiana Stolz3, Gernot Rohde3.
Abstract
First published in 2006, the first European core syllabus in Adult Respiratory Medicine was developed with the intention of harmonising education and training throughout Europe. Internationally recognised by the European Union of Medical Specialists and identified as the first document of its kind in respiratory medicine, it has provided a comprehensive guide for both local and national institutions in the development of adult respiratory training programmes. Like all fields in education, respiratory medicine is an ever-changing area and as such, respective syllabi, curricula and training programmes must adapt and diversify in line with the evolution of core medical concepts. Given the proven importance of the Adult Respiratory Medicine syllabus from both a national and international standpoint, it is of equal importance that said syllabus remains abreast of emerging trends so as to sustain the synchronisation of respiratory medicine in Europe. In order to develop an updated programme, a comprehensive review process of the current syllabus is a necessary endeavour and a step that the European Respiratory Society (ERS) has undertaken through the process of a needs assessment.Entities:
Year: 2018 PMID: 29515664 PMCID: PMC5832014 DOI: 10.1183/20734735.019317
Source DB: PubMed Journal: Breathe (Sheff) ISSN: 1810-6838
Task force members
| Switzerland | |
| UK | |
| Austria | |
| Germany | |
| Hungary | |
| UK | |
| Austria | |
| France | |
| Belgium | |
| Greece | |
| Germany | |
| Poland | |
| The Netherlands |
Adult Respiratory Medicine – Syllabus for trainees
| 1 Anatomy and development (including malformations) |
| 2 Immunology and defence mechanisms |
| 1 Ventilation (theory) |
| 2 Circulation (theory) |
| 3 Control of breathing (theory) |
| 4 Control of ventilation (theory) |
| 5 Respiratory mechanics (diagnostics) |
| 6 Gas exchange (diagnostics) |
| 7 Arterial blood gas and acid–base status assessment (diagnostics) |
| 8 Exercise testing (diagnostics) |
| 9 Bronchial challenge testing (diagnostics) |
| 10 Lung function tests (interpretation) |
| 1 Symptoms |
| 2 Signs |
| 3 Syndrome based approach to diagnosis and differential diagnosis |
| 1 Endoscopic techniques items |
| 1.1 Bronchoscopy |
| 1.2 Endobronchial ultrasound (EBUS) and oesophageal ultrasound (EUS) |
| 1.3 Thoracoscopy |
| 2 Thoracocentesis including closed pleural biopsy |
| 3 Imaging techniques |
| 3.1 Chest radiography |
| 3.2 Thoracic ultrasound |
| 3.3 Computed tomography (CT) scan |
| 3.4 Positron emission tomography (PET) CT |
| 4 Assessment of airway inflammation |
| 4.1 Exhaled nitric oxide fraction ( |
| 4.2 Sputum assessment |
| 5. Basic microbiological methods |
| 1 Pharmacotherapy |
| 1.1 Inhaled drug therapy |
| 1.2 Systemic pharmacotherapy |
| 2 Immunotherapy |
| 2.1 Allergen-specific immunotherapy |
| 2.2 Lung cancer immunotherapy |
| 3 Respiratory physiotherapy |
| 4 Pulmonary rehabilitation |
| 5 Palliative care |
| 6 Oxygen therapy |
| 7 Preventive measures |
| 8 Smoking prevention and cessation |
| 9 Assisted ventilation |
| 10 Chest tube insertion |
| 11 Advanced treatment modalities |
| 11.1 Endobronchial interventions |
| 11.2 Lung volume reduction (surgical and endoscopic lung volume reduction (ELVR)) |
| 11.3 Lung transplantation |
| 1 Evaluation |
| 2 Differential diagnosis |
| 3 Immediate management steps |
| 4 First-line treatment |
| 5 Specific conditions |
| 1 Upper airway diseases |
| 2 Asthma |
| 3 Bronchitis |
| 4 Chronic obstructive pulmonary disease (COPD) and emphysema |
| 5 Bronchiolitis |
| 6 Bronchiectasis |
| 7 Rare airway diseases |
| 8 Congenital airway disease |
| 1 Upper respiratory tract infections |
| 2 Lower respiratory tract infections |
| 3 Pleural infections |
| 4 Lung abscess and other infections |
| 5 Influenza, pandemics and severe acute respiratory syndrome (SARS) |
| 6 Infections in the immunocompromised host |
| 7 Aspiration pneumonitis |
| 1 Pulmonary tuberculosis (TB) including multidrug-resistant (MDR)/extensively drug resistant (XDR)-TB |
| 2 Extrapulmonary TB |
| 3 Latent tuberculous infection |
| 4 Non-tuberculous mycobacterial diseases |
| 1 Lung tumours |
| 1.1 Lung cancer (include paraneoplastic syndromes) |
| 1.2 Other lung tumours |
| 1.3 Metastatic pulmonary tumours |
| 1.4 Solitary nodules |
| 2 Pleural tumours |
| 2.1 Mesothelioma |
| 2.2 Other pleural tumours |
| 3 Chest wall tumours |
| 4 Mediastinal tumours |
| 1 Obstructive sleep apnoea syndrome |
| 2 Central sleep apnoea syndrome |
| 3 Hypoventilation syndromes |
| 4 Dysfunctional breathing/hyperventilation syndrome |
| 1 Acute respiratory failure |
| 2 Chronic respiratory failure |
| 1 Hypersensitivity pneumonitis |
| 2 Sarcoidosis |
| 3 Idiopathic interstitial pneumonias |
| 4 Cryptogenic organising pneumonia of unknown aetiology/bronchiolitis obliterans organising pneumonia |
| 5 Connective tissue disease related interstitial lung disease |
| 6 Langerhans cell histiocytosis |
| 7 Lymphangioleiomyomatosis (LAM) |
| 8 Pulmonary alveolar proteinosis |
| 9 Amyloidosis |
| 10 Drug-induced disease |
| 11 Radiation-induced disease |
| 12 Nonasthmatic eosinophilic bronchitis |
| 13 Acute and chronic eosinophilic pneumonia |
| 14 Hypereosinophilic syndrome |
| 1 Thromboembolic disease |
| 2 Pulmonary hypertension |
| 3 Vasculitis and diffuse pulmonary haemorrhage |
| 4 Arteriovenous malformation |
| 1 Chest wall deformities |
| 2 Neuromuscular disorders |
| 3 Diaphragmatic disorders |
| 1 Pleural effusion |
| 2 Pneumothorax |
| 3 Mediastinitis |
| 1 Primary immunodeficiency syndromes |
| 2 Secondary immunodeficiency syndromes/immunosuppression |
| 3 Cardiac disease |
| 4 Gastrointestinal, liver and kidney disease |
| 5 Haematological disease |
| 6 Obesity |
| 7 Connective tissue diseases |
| 1 Cystic fibrosis |
| 2 Primary ciliary dyskinesia |
| 3 α1-antitrypsin deficiency |
| 4 Birt–Hogg–Dubé syndrome |
| 1 Respiratory hazards associated with occupational factors |
| 2 Acute inhalation injuries and their possible sequelae |
| 3 Occupational respiratory infections including in healthcare workers |
| 4 Work-related asthma (including occupational asthma and work-exacerbated disease) |
| 5 COPD and work |
| 6 Interstitial lung disease (ILD) caused by inorganic agents |
| 7 ILD caused by dusts of biological origin (including extrinsic allergic alveolitis) |
| 8 Asbestos-related conditions other than bronchopulmonary cancer (but including mesothelioma) |
| 9 Occupational causes of bronchopulmonary cancer |
| 1 Epidemiological and statistic methods for critical appraisal |
| 2 Indoor pollution |
| 3 Outdoor pollution |
| 4 High-altitude and diving |
| 5 Lifestyle (smoking, e-cigarettes, nutrition and activity) |